Startups
Switch Therapeutics
Preclinical RNAi biotechnology company developing conditionally activated siRNA therapeutics, initially focused on central nervous system diseases. Distinct from the Switch recruiting app.
Team
No team members on record yet.
Investments
No investment rounds on record yet.